Toxicity evaluation of gold-dendrimer composite nanodevices in vitro - Difference found between tumour and proliferating endothelial cells

Nanotoxicology

Volumn 3, Issue 2, 2009, Pages 139-151

  Nair, Bindu M ^a   Kariapper, Muhammed S T ^a   Lesniak, Wojciech G ^a   Tan, Wei ^a   Hutson, Alan ^a,b   Khan, Mohamed K ^a   Balogh, Lajos P ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Angiogenesis; Composite nanodevice; Nanocomposite; Nanoparticle; PAMAM dendrimer; Toxicity; Tumour

Indexed keywords

DENDRIMER; GOLD;

ANIMAL CELL; ARTICLE; BIOSAFETY; CELL PROLIFERATION; COMPOSITE MATERIAL; CONTROLLED STUDY; ENDOTHELIUM CELL; EVALUATION; HUMAN; HUMAN CELL; MALE; NANODEVICE; NONHUMAN; PRIORITY JOURNAL; RAT; SURFACE CHARGE; TOXICITY TESTING; TUMOR CELL;

EID: 68149181524     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.1080/17435390902725922     Document Type: Article

References (41)

1. Balogh L, Swanson DR, Spindler R, Tomalia DA. 1997. Formation and characterization of dendrimer-based water soluble inorganic nanocomposites. Proc ACS PMSE. pp 118-119.
2. Balogh L, Valluzzi R, Laverdure KS, Gido SP, Hagnauer GL, Tomalia DA. 1999. Formation of silver and gold dendrimer nanocomposites. J Nanoparticle Res 1:353-368.
3. Balogh L, Bielinska A, Eichman JD, Valluzzi R, Lee I, Baker JR, Lawrence TS, Khan MK. 2002. Dendrimer nanocomposites in medicine. Chimica Oggi (Chem Today) 20:35-40.
4. Balogh L, Nigavekar SS, Nair BM, Lesniak W, Zhang C, Sung LY, Kariapper MST, et al. 2007. Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models. Nanomed: Nanotechnol, Biol Med 3:281-296.
5. Balogh LP, Khan MK. 2007. Dendrimer nanocomposites for cancer therapy. Boca Raton, FL: CRC Press/Taylor & Francis Group.
6. Balogh LP, Nigavekar SS, Cook AC, Minc L, Khan MK. 2003. Development of dendrimer-gold radioactive nanocomposites to treat cancer microvasculature. PharmaChem 2:94-99.
7. Bosman AW, Janssen HM, Meijer EW. 1999. About dendrimers: Structure, physical properties, and applications. Chem Rev 99:1665-1688.
8. Eichman JD, Bielinska AU, Kukowska-Latallo JF, Baker JR. 2000. The use of PAMAM dendrimers in the efficient transfer of genetic material into cells. Pharmaceut Sci Technol Today 3:232-245.
9. Ely TO, Sharma M, Wojcieh LG, Klippenstein DL, Foster BA, Balogh LP. 2007. Dendrimer nanocomposites as multifunctional X-ray contrast agents. Materials Research Society Fall Meeting Quantum-Dot and Nanoparticle Bioconjugates - Tools for Sensing and Biomedical Imaging. Hynes Convention Center, Boston, MA.
10. Hodge P. 1993. Polymer science branches out. Nature 362:18-19.
11. Hong S, Bielinska AU, Mecke A, Keszler B, Beals JL, Shi X, Balogh L, Orr BG, Baker JRJr, Banaszak Holl MM. 2004. Interaction of poly(amidoamine) dendrimers with supported lipid bilayers and cells: hole formation and the relation to transport. Bioconjug Chem 15:774-782.
12. Jevprasesphant R, Penny J, Jalal R, Attwood D, McKeown NB, D'Emanuele A. 2003. The influence of surface modification on the cytotoxicity of PAMAM dendrimers. Int J Pharmaceut 252:263-266.
13. Khan MK, Nigavekar SS, Minc LD, Kariapper MST, Nair BM, Lesniak WG, Balogh LP. 2005. In vivo biodistribution of dendrimers and dendrimer nanocomposites - implications for cancer imaging and therapy. Technol Cancer Res Treatment 4:603-613.
14. Khan MK, Nigavekar SS, Minc L, Nair BM, Kariapper MT, Lesniak WG, Balogh LP. 2006. Significant size-charge effects on the biodistribution of nanocomposites in a mouse tumor model system. Am Assoc Cancer Res Meeting Abstracts. 258b
15. Khan MK, Minc LD, Nigavekar S, Kariapper MST, Nair BM, Schipper M, Cook AC, Lesniak WG, Balogh LP. 2008. Fabrication of radioactive gold/dendrimer composite nanodevices and their use for nanobrachytherapy. Nanomed: Nanotechnol. Biol Med 4:57-69.
16. Khandare J, Kolhe P, Pillai O, Kannan S, Lieh-Lai M, Kannan RM. 2005. Synthesis, cellular transport, and activity of polyamidoamine dendrimer-methylprednisolone conjugates. Bioconjugate Chem 2005:330-337.
17. Kitchens KM, El-Sayed MEH, Ghandehari H. 2005. Transepithelial and endothelial transport of poly (amidoamine) dendrimers. Adv Drug Deliv Rev 57:2163-2176.
18. Kolhatkar RB, Kitchens KM, Swaan PW, Ghandehari H. 2007. Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability. Bioconjugate Chem 18:2054-2060.
19. Lam CW, James JT, McCluskey R, Arepalli S, Hunte RL. 2006. A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks. Crit Rev Toxicol 36:189-217.
20. Lesniak W, Bielinska AU, Sun K, Janczak KW, Shi X, Baker JR, Balogh LP. 2005. Silver/dendrimer nanocomposites as biomarkers: Fabrication, characterization, in vitro toxicity, and intracellular detection. Nano Lett 5:2123-2130.
21. Lesniak WG, Kariapper MST, Nair BM, Tan W, Hutson A, Balogh LP, Khan MK. 2007. Synthesis and characterization of PAMAM dendrimer-based multifunctional nanodevices for targeting αvβ3 integrins. Bioconjugate Chem 18:1148-1154.
22. Majoral JP, Caminade AM. 1999. Dendrimers containing heteroatoms (Si, P, B, Ge, or Bi). Chem Rev 99:845-880.
23. Malik N, Wiwattanapatapee R, Klopsch R, Lorenz K, Frey H, Weener JW, Meijer EW, Paulus W, Duncan R. 2000. Dendrimers: Relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. J Control Release 65:133-148.
24. Maurice WPL, Baars A, Meijer EW. 2000. Dendrimers II. Architecture, Nanostructure Supramolec Chem 210:131-182.
25. Myc A, Majoros IJ, Thomas TP, Baker Jr JR. 2007. Dendrimer-based targeted delivery of an apoptotic sensor in cancer cells. Biomacromolecules 8:13-18.
26. Newkome GR, Moorefield CN, Vogtle F. 2001. Dendrimers and dendrons: Concepts, syntheses, applications. New York: Wiley VCH.
27. Nigavekar SS, Sung LY, Llanes M, El-Jawahri A, Lawrence TS, Becker CW, Balogh L, Khan MK. 2004. 3H dendrimer nanoparticle organ/tumor distribution. Pharmaceut Res 21:476-483.
28. Quintana A, Raczka E, Piehler L, Lee I, Myc A, Majoros I, Patri AK, Thomas T, Mule J, Baker JRJr. 2002. Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor. Pharm Res 19:1310-1316.
29. Roberts JC, Bhalgat MK, Zera RT. 1996. Preliminary biological evaluation of polyamidoamine (PAMAM) Starburst dendrimers. J Biomed Mater Res 30:53-65.
30. Seib FP, Jones AT, Duncan R. 2007. Comparison of the endocytic properties of linear and branched PEIs, and cationic PAMAM dendrimers in B16f10 melanoma cells. J Controlled Release 117:291-300.
31. Service RF. 2006. Science policy. Priorities needed for nano-risk research and development. Science 314:45.
32. Shukla R, Thomas TP, Peters JL, Desai AM, Kukowska-Latallo J, Patri AK, Kotlyar A, Baker JR Jr. 2006. HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb. Bioconjugate Chem 17:1109-1115.
33. Smith CJ, Shaw BJ, Handy RD. 2007. Toxicity of single walled carbon nanotubes to rainbow trout, (Oncorhynchus mykiss): Respiratory toxicity, organ pathologies, and other physiological effects. Aquatic Toxicol 82:94-109.
34. Tan NB, Balogh L, Trevino S. 1997. Structure of metallo-organic nanocomposites produced from dendrimer complexes. Proc ACS Polymeric Materials: Science and Engineering 77:120.
35. Thomas TP, Majoros IJ, Kotlyar A, Kukowska-Latallo JF, Bielinska A, Myc A, Baker JRJr. 2005. Targeting and inhibition of cell growth by an engineered dendritic nanodevice. J Medicinal Chem 48:3729-3735.
36. Tomalia DA, Baker H, Dewald J, Hall M, Kallos G, Martin S, Roeck J, Ryder J, Smith P. 1984. New class of polymers: Starbust-dendritic macromolecules. Polymer J 17:117-132.
37. Tomalia DA, Balogh L. 2003. Nanocomposites of dendritic polymers. US patent 6,664,315 B2.
38. Tomalia DA, Balogh L. 2006. Nanocomposites of dendritic polymers. US patent 6,995,234.
39. Tomalia DA, Reyna LA, Svenson S. 2007. Dendrimers as multipurpose nanodevices for oncology drug delivery and diagnostic imaging. Biochem Soc Transact 35:61-67.
40. Witzmann FA, Monteiro-Riviere NA. 2006. Multi-walled carbon nanotube exposure alters protein expression in human keratinocytes. Nanomed: Nanotechnol, Biol Med 2:158-168.
41. Zheng L, Hulderman T, Salmen R, Chapman R, Leonard SS, Young S-H, Shvedova A, Luster MI, Simeonova PP. 2007. Cardiovascular effects of pulmonary exposure to single-wall carbon nanotubes. Environ Health Perspect 115:377-382.